Choroid plexus carcinoma

A choroid plexus carcinoma (WHO grade III) is a type of choroid plexus tumor [1] that affects the choroid plexus of the brain. It is considered the worst of the three grades of chord plexus tumors, having a much poorer prognosis than choroid atypical plexus papilloma (WHO grade II) and choroid plexus papilloma (WHO grade I).[2] The disease creates lesions in the brain and increases cerebrospinal fluid volume, resulting in hydrocephalus.[3]

Choroid plexus carcinoma
Photomicrograph of hematoxylin-eosin stained section of a choroid plexus carcinoma (grade III WHO) at 400x magnification.
SpecialtyOncology

Signs and symptoms

The symptoms of choroid plexus carcinoma are similar to those of other brain tumors. They include:[4]

Cause

The cause of choroid plexus carcinomas are relatively unknown, although hereditary factors are suspected. The sometimes occur in conjunction with other hereditary cancers, including Li–Fraumeni syndrome and malignant rhabdoid tumors. A mutation in the tumor suppressor gene TP53 is usually characterized in this disease.[5]

Pathophysiology
Main article: Carcinogenesis

Choroid plexus carcinomas typically occur in the lateral ventricles in children and in the fourth ventricle of adults. The third ventricle is the least common ventricle effected. This is unlike most other pediatric and adult tumors, as the locations of the tumors are typically reversed. These tumors are usually found in the infratentorial region in children and in the supratentorial space in adults.[6] Choroid plexus carcinomas can induce hydrocephalus through a variety of mechanisms, including blockage of normal cerebrospinal fluid (CSF) flow, the tumor overproducing CSF, spontaneous hemorrhage, and expansion of the ventricles.[7]

The tumors most frequently spread through the CSF. As a result, metastases frequently occur along the central nervous system, particularly in the leptomeninges. In rare cases, metastases have been reported to spread to the abdomen and extra-cranial sites.[8]

Treatment

Treatment of choroid plexus carcinoma depends on the location and severity of the tumor. Possible interventions include inserting shunts, surgical resection, radiotherapy, and chemotherapy. Inserting a shunt could help to drain the CSF and relieve pressure on the brain. The best outcomes occur when total resection of the tumor is combined with adjuvant chemotherapy and radiotherapy.[9] In the event of subtotal resection or widespread leptomeningeal disease, craniospinal irradiation is often used.[8]

Incidence

Choroid plexus tumors have an annual incidence of about 0.3 per 1 million cases.[7] It is seen mainly in children under the age of 5,[4] representing 5% of all pediatric tumors and 20% of tumors in children less than 1 year old.[6] There has been no link between sex and occurrence.[10]

Although choroid plexus carcinomas are significantly more aggressive and have half the survival rate as choroid plexus papillomas, they are outnumbered in incidence by 5:1 in all age groups.[10][11] Clinical studies have shown that patients who receive a total resection of a tumor have an 86% survival rate, while patients who only receive a partial resection have a 26% 5-year survival rate. Many incomplete resections result in recurrence within 2 years of primary surgery.[12]

See also

References
  1. Gopal P, Parker JR, Debski R, Parker JC (August 2008). "Choroid plexus carcinoma". Arch. Pathol. Lab. Med. 132 (8): 1350–4. doi:10.1043/1543-2165(2008)132[1350:CPC]2.0.CO;2 (inactive 2021-01-11). PMID 18684041.CS1 maint: DOI inactive as of January 2021 (link)
  2. Stanislavsky, A. "Choroid plexus carcinoma". Radiopaedia.
  3. Oliver Adunka; Craig Buchman (11 October 2010). "Management of Middle Ear Trauma". Otology, Neurotology, and Lateral Skull Base Surgery: An Illustrated Handbook. Thieme. doi:10.1055/b-0034-83637. ISBN 9783131450210.
  4. McEvoy AW, Harding BN, Phipps KP, et al. (April 2000). "Management of choroid plexus tumours in children: 20 years experience at a single neurosurgical centre". Pediatr Neurosurg. 32 (4): 192–9. doi:10.1159/000028933. PMID 10940770. S2CID 20244382.
  5. Dricua A, et al. (Dec 1999). DNA Methylation, Stem Cells and Cancer.
  6. Rickert CH, Paulus W (Jan 2001). "Tumors of the choroid plexus". Microscopy Research and Technique. 52 (1): 104–11. doi:10.1002/1097-0029(20010101)52:1<104::AID-JEMT12>3.0.CO;2-3. PMID 11135453.
  7. Menon G, Nair SN, Baldawa SS, Rao RB (May–June 2010). "Choroid plexus tumors: an institutional series of 25 patients". Neurology India. 58 (3): 429–35. doi:10.4103/0028-3886.66455. PMID 20644273.
  8. Meyers SP, et al. (Sep 2004). "Choroid plexus carcinomas in children: MRI features and patient outcomes". Neuroradiology. 46 (9): 770–80. doi:10.1007/s00234-004-1238-7. PMID 15309348. S2CID 22235664.
  9. Cannon DM, et al. (Jan 2015). "Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management". Journal of Neuro-Oncology. 121 (1): 151–7. doi:10.1007/s11060-014-1616-x. PMID 25270349. S2CID 11127634.
  10. Louis D, et al. (Aug 2007). "The 2007 WHO Classification of Tumours of the Central Nervous System". Acta Neuropathologica. 114 (2): 97–109. doi:10.1007/s00401-007-0243-4. PMC 1929165. PMID 17618441.
  11. Ogiwara H, et al. (Feb 2012). "Choroid plexus tumors in pediatric patients". British Journal of Neurosurgery. 26 (1): 32–7. doi:10.3109/02688697.2011.601820. PMID 21970783. S2CID 12096860.
  12. Berger C, et al. (Mar 1998). "Choroid plexus carcinomas in childhood: clinical features and prognostic factors". Neurosurgery. 42 (3): 470–5. doi:10.1097/00006123-199803000-00006. PMID 9526979.
Classification
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.